Skip to product information
1 of 2

TCI

CAS 174671-46-6

Tavaborole TCI T3775

Tavaborole TCI T3775

Chemical Identity

CAS No.
174671-46-6
PubChem
CID 11499245·SID 468592937
Formula
C7H6BFO2
Molecular weight
151.93 g/mol
Purity
>98.0%(HPLC)
Reference databases
ChEBI·ChemSpider·ECHA·Wikipedia
Full identifiers (IUPAC, SMILES, InChIKey)
IUPAC
5-fluoro-1-hydroxy-3H-2,1-benzoxaborole
SMILES
B1(C2=C(CO1)C=C(C=C2)F)O
InChIKey
LFQDNHWZDQTITF-UHFFFAOYSA-N
Regular price Rp 2.173.500,00
Regular price Rp 1.535.100,00 Sale price Rp 2.173.500,00
Sale Sold out
Shipping calculated at checkout.
Berat
Quantity
Pembayaran hanya melalui request quotation dan dilakukan setelah tim kami menghubungi Anda. Mohon cantumkan nomor WhatsApp aktif untuk konfirmasi pesanan & pembuatan invoice. Estimasi pengiriman 2-4 minggu setelah pembayaran.

Dokumen Keamanan & Mutu

CoA (Certificate of Analysis)

Spesifik per batch produksi — diterbitkan dan dikirim bersama barang sesuai nomor lot yang Anda terima.

Contoh CoA segera tersedia.

💬 Minta CoA via WhatsApp

View full details

Tavaborole (CAS 174671-46-6) is a high-quality chemical from TCI, supplied as HPLC Grade.

Application: Synthesis reagent for a wide range of organic chemistry transformations in laboratory and industrial settings.

Specifications:

  • Molecular formula: C7H6BFO2
  • CAS number: 174671-46-6
  • Purity: >98.0%(HPLC)
  • TCI product code: T3775

Synonyms: 5-Fluorobenzo[c][1,2]oxaborol-1(3H)-ol; AN-2690

Available from AMI Scientific, the authorised TCI distributor in Indonesia. Contact us for pricing and stock availability — we ship throughout Indonesia.

Advantages (TCI brochure)

  • Benzoxaborole drug with leucyl t-RNA synthase inhibitor mechanism of action

From the TCI brochure

  • Pharmacologically active compound (leucyl t-RNA synthase inhibitor)

Brand —
CAS number —
Molecular formula —
Purity —
Category —
Pack sizes —
Physical form —
Storage —

Data from the TCI brochure

Ukuran kemasan250mg

Source: TCI brochure RR200 (2025-04-01)

—

References cited in the TCI brochure

  1. Shu Song. Recent developments in the medicinal chemistry of single boron atom-containing compounds Acta Pharmaceutica Sinica B, 2021. doi:10.1016/j.apsb.2021.01.010
  2. Katia Messner. The Boron Advantage: The Evolution and Diversification of Boron’s Applications in Medicinal Chemistry Pharmaceuticals, 2022. doi:10.3390/ph15030264